跳至主要内容
临床试验/IRCT2015083123834N1
IRCT2015083123834N1已完成未知

The effect of compound Ma-ol-asal on clinical manifestation of the pediatric asthma

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • patients with asthma aged 6-16 years old that referred to the pulmonary clinic of the Mofid Children's Hospital, Tehran, Iran; patients who are willing and consent to participate in the study.
  • Exclusion criteria: Patients under 6 and over 16 yearsold; patients with modprate asthma; patients with severe asthma; patients requiring hospitalization and patients who have attack; patients with underlying diseases such as CF, Bronchopulmonary dysplasia, heart failure, bronchotracheomalacia, GERD, bronchiectasis, Pulmonary embolism and sarcoidosis; patients who are taking medications such as aspirin, beta blocker and NSAID's; patients who become affected to other acute disease during the study; patients who are allergic to any components of compound Ma-ol-asal and request and patients who have decision to excluded from the study.

排除标准

  • 未提供

研究者

相似试验